WASHINGTON (AP) - U.S. government health officials are alerting doctors to the recall of an injectable antibiotic made by B. Braun Medical Inc., due to floating particles found in vials of the drug.
The Food and Drug Administration posted the notice Tuesday, warning health professionals that the company, a U.S. subsidiary of the German pharmaceutical firm B. Braun Melsungen, has recalled lot H3A7444 of its Cefepime for Injection USP and Dextrose Injection USP. Visible particles were found in a sample from the lot, including specs of metal, cotton fiber and hair.
The agency warned that using the drug could result in blood clots causing stroke, heart attack and other catastrophic problems.
The drug was distributed to hospitals, pharmacies and medical suppliers nationwide, according to the agency's release.
Patients experiencing health problems should contact their physician.
(Copyright 2013 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.)
Don't let erectile dysfunction derail your dating life. Learn how to manage your ED and talk about it with a new partner.
Patients who had scans at shorter intervals had less lymph node involvement, study found
ADHD, depression most common conditions reported by those on medication
Experts unsure exactly why, but better prevention and after-stroke care may be factors
Researchers say period from infection to disease takes about 5 years
FORT LAUDERDALE, Fla. (AP) — Counselors helping people use the federal government's online health exchange are giving mixed reviews to the updated site, with some zipping through the application process while others are facing the same old sputters and even crashes.
Are you and your smartphone inseparable? If so, you're not alone -- plenty of research illustrates how increasingly addicted we're becoming to our mobile devices, including one survey showing that 66 percent of people are actually afraid to lose or be separated from their cell phones. And if rising rates of sleep texting aren't enough to signal our addiction to our cell phones, we don't know what is. The iPhone is the most popular smartphone in America, and its latest incarnation, the iPhone 5s, was released in the U.S. last Friday to much frenzy and fanfare. But before you get
Uncertain corporate costs for President Barack Obama's healthcare reform law and other regulations continue to stymie U.S. employment and capital spending, business leaders said on Wednesday. Roughly 39 percent of U.S. chief executives cited regulatory costs as their top concern for the next six months, according to a survey released by the Business Roundtable, a confederation of top U.S. companies. The group said uneven implementation of the healthcare law, commonly known as Obamacare, has made it tough for businesses to decide where to allocate capital for new construction or hiring. "There seems to be an exception every other day on the Affordable Care Act," Jim McNerney, head of the Business Roundtable and chief executive of airplane maker Boeing Co, said in a conference call on Wednesday, using the law's formal name.